Dexamethasone (DM) is a synthetic member of the glucocorticoid (GC) class of hormones that possesses anti-inflammatory and immunosuppressant activity and is commonly utilized to treat chronic inflammatory disorders, severe allergies and other disease states. While GC are known to mediate well-defined transcriptional effects via GC receptors (GCR), there is increasing evidence that GC also initiate rapid non-genomic signaling events in a variety of cell types. Here, we report that DM induces the 
Introduction
GC are used to treat diseases with an inflammatory or immune-mediated component, including autoimmune diseases, graft rejection and leukemia. GC act via the T-cell intracellular GCR and may negatively regulate the expression of numerous genes associated with proinflammatory cytokines signaling 1, 2 . This inhibition of gene transcription appears to result from the ability of the GC:GCR complex to interfere with the activity of numerous transcription factors, either by binding to negative regulatory elements in the promoter region or through protein/protein interactions, impeding the ability of these factors to positively direct gene transcription 3 . In addition to these genomic effects, several studies have also described non-genomic, rapid effects of GCs on immune cells [4] [5] [6] [7] . DM can attenuate the early events of the TCR-induced signaling cascade, including the activation of Src kinases via the GCR. GCR-deficient Jurkat cells and human T cells treated with the GCR blocker, Ru486, during cell activation failed to demonstrate any inhibition in kinase activation in response to DM. Interestingly, many of the inhibitory effects of GC have been observed in activated human or rodent T cells and immune cell subpopulations; however, the effects of DM on resting T cells are unclear.
CXCR4, a chemokine receptor specific for the chemokine ligand, CXCL12, is expressed on leukocytes and is involved in the recirculation of naive lymphocytes into lymphoid tissue 8 . This receptor also plays a role in the retention of stem cells, differentiating B cells and neutrophils within bone marrow 9 and controls B cell positioning within lymph nodes, where its expression is regulated by IL-4 10 . CXCR4 has been found to play a critical role in thymocyte chemotaxis and apoptosis 11 as well as
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From thymic development 12 . CXCL12 was found to counteract the effects of DM on the apoptosis of CD4+CD8+ T cells. Interestingly, several reports have also demonstrated that exposure of T cell lines to GC can upregulate cell surface CXCR4 expression 13, 14 .
Signals delivered through CXCR4-CXCL12 interactions result in potent chemotactic and pro-adhesive signals facilitating T-and B-lymphocyte migration [15] [16] [17] . Several reports have suggested that the activation of the Src kinase, Lck, upon treatment of T-cells with CXCL12 may be involved in orchestrating the downstream signals necessary for chemotaxis 18, 19 . CXCR4 physically associates with the TCR upon CXCL12 ligation and utilizes the ZAP-70 binding ITAM domains of the TCR for signal transduction 20 . This association may actually account for several activities attributed to CXCR4 activation including ERK activation, intracellular calcium mobilization, enhanced AP-1 activity and cytokine production. These findings suggest a signaling linkage between the TCR and CXCR4 signaling pathways.
Here, we demonstrate that the treatment of resting T cells with the GCR agonist, DM, significantly enhances CXCR4-mediated signaling and function possibly via the activation of Lck and several down stream kinases. The treatment of resting but not activated T cells with either CXCL12 or DM resulted in the activation of these kinases in a synergistic manner. Interestingly, the DM effects were found to actually require the presence of Lck, CD45 and the GCR. The relevance of these data to TCR and CXCR4 signaling shall be discussed.
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Materials and Methods

Reagents and Supplies
CXCL12 was purchased from PeproTech (Rocky Hill, NJ). Polyclonal and monoclonal antibodies against Lck and Protein A/G PLUS agarose beads, monoclonal antiphosphotyrosine antibody (4G20) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The antibody for anti-human CD3 and CD28 was purchased from BD Pharmingen (San Jose, CA). The antibody for Fyn, Zap70, CD48, CD45, CXCR4, Csk, CD4, Vav1 and Vav2 were purchased from Upstate Biotechnology (Charlottesville, VA) or abCAM (Cambridge, UK). The activated Rac1 kits were purchased from Chemicon International (Temecula, CA). Monoclonal anti-CXCR4 antibody for FACS was purchased from BD Pharmingen. Dexamethasone (98% pure) and the blockers damnacanthal, lavendustin-A, genistein, staurosporine, RU486 and wortmannin were purchased from Sigma Chemical Company (St. Louis, MO). The biochemical assay kit for CD45 was purchased from Biomol International (Plymouth, PA). A non cell permeable CD45 specific inhibitor, RK-682 was purchased from Calbiochem (Darmstard, Germany). Cholera toxin and phalloidin labeled with alexfluor488 were purchased from Molecular Probes (Carlsbad, CA). Custom made gel and other chemicals for western blot were purchased from Invitrogen (Carlsbad, CA).
T cell lines and cultures
The human T cell line, Jurkat cells (JE6.1) and the Jurkat cell lines deficient for Lck (JCaM 1.6), CD45 (J45.01) and the T cell receptor beta chain (JRT 3.1) were obtained 
Flow cytometric analysis (FACS)
FACS analysis was utilized to analyze the status of CXCR4 or CD4 or actin polymerization in different cell lines and primary T cells as previously described 22, 23 . For assessment of actin polymerization, phalloidin labeled with alexfluor-488 was utilized. In parallel, the cells were treated with isotype immunoglobulin as a control. The samples were examined using a flow cytometer (FACScan, Becton Dickinson, CA, USA).
Chemotaxis and Intracellular calcium assays
Measurement of chemotaxis and calcium mobilization in response to DM or CXCL12 stimulation were also performed as previously described 22, 23 and discussed in the Figure   legends . In the chemotaxis studies, the data are expressed as "PMI" or the percent migration index 22, 23 . For intracellular calcium measurement, the data are presented as the relative ratio of fluorescence excited at 340 and 380 nm.
Statistical analysis
All the data were always repeated at least three times using duplicate or triplicate determination throughout the work. Student t-test was used for statistical analysis and p<0.05 level was considered as significant wherever applicable. Similarly here, we have found that the addition of DM to human T cells (Fig 1A, upper panel) and Jurkat T cell cultures (Fig 1A, lower) during anti-CD3 and anti-CD28 mAb activation resulted in a significant reduction of Lck phosphorylation (range of 0.5-3 fold).
In contrast, we found that DM treatment of human resting T cells (Fig 1A, upper panel) and Jurkat T cells (Fig 1A, lower panel) resulted in a significant induction (>2.5 fold) in the level of phosphorylated Lck. This result was surprising considering the established role of DM as an anti-inflammatory mediator and inhibitor of T cell activation.
Interestingly, treatment of resting T cells with the chemokine, CXCL12 also demonstrated a dramatic increase in Lck phosphorylation (>2.5 fold), while no significant change in the Lck phosphorylation status was observed in the activated T cell cultures.
Moreover, a prominent additive effect on the Lck phosphorylation was observed in the resting T cell populations upon addition of both DM and CXCL12, while addition of CXCL12 with DM to the activated cell cultures failed to demonstrate any significantly greater inhibition in Lck phosphorylation when compared to DM treatment alone ( Fig   1A) . These results suggest that DM exerts a differential effect on Lck phosphorylation depending on the activation state of the T cell and may provide an activation signal to resting T cells. Kinetic analysis of DM-mediated Lck phosphorylation (Sup Fig 1A) demonstrated that exposure of these cells to DM between 5 to 15 minutes resulted in the For personal use only. on September 24, 2017. by guest www.bloodjournal.org From optimal phosphorylation of Lck followed by a significant decline in the magnitude with prolonged exposure.
Lck is a Src-family tyrosine kinase expressed in T lymphocytes, where it participates in the cellular immune response. Lck associates through its distinctive aminoterminal segment with the cytoplasmic tails of the CD4 and CD8 molecules. Activated Lck phosphorylates TCRε chains, which then recruit the ZAP70 kinase to promote T-cell activation. Lck is activated by autophosphorylation at Tyr394 and it is inactive when Tyr505 near the carboxy terminus is phosphorylated. Here, we have observed that, in resting T cells, tyrosine phosphorylation of Lck at Y394 is increased in the CXCL12 and/or DM treated samples with much lower levels of phospho-Y505 being observed in the same treated groups (Sup Fig 1B) . However, in the activated cultures, the opposite results were observed with a dramatic reduction in Y394 phosphorylation in the DM, Lck kinase activity was observed in response to both DM and CXCL12 with an even more dramatic induction (~ 5-fold) when these treatments were combined (Sup Fig 2A) .
These data re I agreement with the increased dissociation of Lck from immunoprecipitated CD4 molecules in resting human T cells and Jurkat T cells upon treatment with DM and/or CXCL12 (Sup Fig 2B) . These data support our hypothesis that DM and CXCL12 provide an Lck activation signal in resting but not activated T cells facilitating its kinase activity and downstream functions.
To determine if DM-mediated Lck phosphorylation is dependent on the presence of GCR, resting human T cells ( Fig 1B) were preincubated with mifepristone, a specific blocker of the GCR, followed by the treatment with DM or CXCL12 alone or in DM potentiates the T cell migration in response to CXCL12 in dose-and timedependent manner. As the requirement of Lck phosphorylation has been shown to be necessary for CXCL12-mediated chemotaxis in T cell 19 and DM appears to augment the CXCL12-induced Lck phosphorylation in resting T cells (Fig 1A) , we have further examined its effects here on the CXCL12-mediated chemotaxis. DM-treated resting human T cells and Jurkat T cells demonstrated a significant increase in their ability to migrate in response to CXCL12 when compared to their vehicle-control treated counterparts (Fig 2A) . This DM-mediated enhancement of migration was found to be dose-dependent with gradually higher concentrations of DM resulting in the significant enhancement (p<0.05) of CXCL12-mediated migration in comparison to vehicle control treated cells (Fig 2B) . Optimal DM effects were observed at 1μM. Kinetic analysis using 1μM of DM on CXCL12-induced migration in Jurkat T cells revealed that an optimal DM-enhanced migratory response was obtained after 120 minutes of preincubation ( Fig 2C) . To assess whether the DM mediated effects on CXCL12-mediated migration were also dependent on Lck activation, we utilized pharmacological inhibitors specific to tyrosine kinase, Src kinase and Lck within our assay system. All of these inhibitors were . Here, resting human T cells and Jurkat were treated with CXCL12 and/or DM followed by an immunoprecipitation of Fyn59 or Zap70. Similar to our other studies, an increase in the phosphorylation of p59Fyn ( Fig 5A) and Zap70 ( Fig 5B) were observed in response to DM and CXCL12 treatment of resting human T cells or Jurkat T cells with an even greater increase using combined treatments.
DM-enhanced CXCL12-induced migration is a GCR-and
DM-induced phosphorylation of Lck is a CD45-dependent phenomenon.
CD45 is a membrane bound phosphatase that plays a critical role as a positive regulator of Lck 26 .
Thus, a possible role for CD45 in the DM-induced phosphorylation of Lck was also examined. Here, we have analyzed the effects of DM and CXCL12 alone or in combination on CD45-specific and total phosphatase activity in Jurkat T cells. The data failed to demonstrate any significant change in CD45 specific (Fig 6A) or total phosphatase activity (data not shown) in response to DM or CXCL12 treatment.
However, blocking of CD45 activity using RK-682, demonstrated a significant attenuation in DM-induced Lck phosphorylation (Fig 6B) compared to vehicle controltreated Jurkat T cells. Moreover, only a partial blocking of CXCL12-induced Lck phosphorylation was observed using this CD45-specific phosphatase inhibitor. These
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From studies suggest that active CD45 is required for the observed DM-and CXCL12-mediated effects on Lck phosphorylation, while not directly inducing any phosphatase activity alone or in combination. The Lck and CD45 requirements are further supported through the by the use of a CD45-deficient Jurkat cell line, J45.01, which failed to elicit any Lck phosphorylation in response to DM or CXCL12 alone or in combination in comparison to wild-type Jurkat cells (Fig 6B) . CD45 deficient line as well as an Lck deficient line, Jcam 1.6, failed to demonstrate any DM-mediated effects on CXCL12-induced migration (Fig 6C) . Moreover, these two deficient cell lines also demonstrated poor migration in response to CXCL12 at any dose tested when compared to migration observed in the wild-type Jurkat cells and primary human T cells (Fig 6C) . The poor migratory effects of the J45.01 and Jcam 1.6 cell lines do not appear to be due to significant differences in the cell surface levels of CXCR4 compared to wild-type Jurkat cells regardless of any treatment (data not shown).
Interactions among GCR, CD45 and Lck upon DM treatment in human T cells. The above data suggest the involvement of GCR, Lck and CD45 in the enhancement of CXCL12-mediated migration by DM and in the ability of DM to mediate Lck activation in resting T cells. It seems possible that there are direct interactions and colocalization of these molecules after DM surpasses the cell membrane. To examine this possibility, we examined the molecular interaction among these three molecules at a single cell level using confocal microscopy. Resting human T cells were treated with DM or CXCL12 alone or in combination and the colocalization of CD45, Lck and GCR were examined using fluorochrome-labeled antibodies. Our results revealed that there was a clear colocalization among CD45, Lck and GCR on the cell membrane upon treatment of For personal use only. on September 24, 2017. by guest www.bloodjournal.org From resting T cells with either CXCL12 or DM but the magnitude of colocalization among these three molecules was highest in combined treatment when compared to DM or CXCL12 treatment alone. No colocalization was observed in vehicle control treated cells (Fig 7A and Sup Fig 3) . Quantitation of the degree of colocalization was found to be significant for DM and CXCL12 alone and even greater in combined cultures (Sup Fig   3) .
Our hypothesis of interactions between these three molecules was further reinforced using reciprocal immunoprecipitation of treated human T cells. CD45 and GCR were immunoprecipitated from DM-or CXCL12-treated resting human T cells and interactions between these molecules were examined using Western blot analysis of CD45, GCR or Lck. These data revealed an interaction between all of these molecules upon treatment with CXCL12 and DM alone or in combination (Fig 7B) . Similar results were revealed examining total Lck immunoprecipitation (data not shown). Vehicle control-treated cells demonstrate little to no basal interaction between these molecules suggesting that DM and/or CXCL12 facilitate an association between Lck, CD45 and GCR. Moreover, we also examined possible associations between CXCR4 and Lck upon DM and CXCL12 treatment. In reciprocal immunoprecipitation, we failed to observe any interactions between CXCR4 and Lck post DM and/or CXCL12 treatment (Sup Fig 4A) . (Fig 3A and 3B ).
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A possible mechanism for this DM enhancement of CXCL12-mediated chemotaxis may be via its ability to modulate the cell surface expression of the CXCL12 receptor, CXCR4, as previously described 13, 14, 33 . There have been several reports demonstrating that glucocorticoids and DM can directly upregulate CXCR4 expression in monocytes and T lymphocytes, resulting in an increased capacity of these cells to migrate in response to CXCL12 13, 14, 33 . However, in those published studies, glucocorticoid treatment required more extensive incubation times (up to 16 hours) before any effects on CXCR4 expression could be observed. In contrast, our DM effects on cell migration were observed as early as 5 minutes after DM treatment with optimal effects on migration being noted at 2 hr, time intervals failed to demonstrate any change in CXCR4 cell surface expression on primary human T cells or Jurkat cells (Sup Fig 5A) . The effects of DM on Lck phosphorylation were observed as early as 2-5 minutes post treatment, suggesting a transcription-independent mechanism controlling CXCR4-mediated migration and signaling (Sup Fig 1A) . ; however, no data concerning the influence of DM on these processes exists. We observed that DM alone induced actin polymerization (Fig 4B and 4C ) and did so synergistically with
CXCL12. DM treatment of T cells and Jurkat cells also promoted the activation of the
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From small GTP binding protein, Rac1 (Fig 4D) and the oncoproteins, Vav1 or Vav2 (Fig 4E; data not shown). These molecules are important signaling components that play an important role in organizing the actin cytoskeleton in T cells or tumor cells [37] [38] [39] . Our data also support the involvement of Lck and Src kinases in DM-mediated enhancement of CXCL12-induced migration and signaling (Fig 1A and 3) . Similar to other reported kinetics for the activation of Lck 40,41 , we also observed maximal Lck phosphorylation occurs between 5 to 15 minutes post DM exposure (Sup Fig 1A) . Previous reports have demonstrated the activation of Lck by CXCL12 19,42 ; however, to date, no studies have reported the direct effects of DM or glucocorticoids on chemokine-induced Lck phosphorylation or migration. Interestingly, DM-mediated enhancement of cell migration ( Fig 3A) was found to be a GCR-dependent event suggesting that direct interactions between DM and GCR are influencing CXCR4 signaling and activity. Another possible means by which DM is facilitating TCR-independent Lck phosphorylation may be via the ability of DM to influence the activity of the CD45 molecule. CD45 is a membrane bound phosphatase that plays a critical role as positive regulator of Lck by site specific dephosphorylation of a tyrosine residue of the Lck regulator Csk, a cognate inhibitory motif for most of the Src kinase 45 . We failed to observe any effects on the cellular CD45-specific or total phosphatase activity in response to DM or CXCL12 (Fig 6A) , which is supported by the earlier work of Laethem et al 46 . However, we did find that DM-induced Lck phosphorylation required the presence of the CD45 molecule as demonstrated by our inhibitor studies (Fig 6B) .
Furthermore, our confocal and immunoprecipitation experiments indicate that DM treatment facilitates a physical interaction between the GCR, CD45 and Lck molecules.
The precise mechanisms mediating these interactions remain unclear.
Several additional studies have been performed in our attempt to determine how DM may facilitate the interactions between CD45 and Lck. One possibility included the potential ability of DM and/or CXCL12 to increased CD45 association with lipid rafts.
CD45 is a membrane bound phosphatase that has positive regulatory role on the kinase domain of Lck through inhibition of negative modulator of Lck molecule Csk. CD45 is almost always localized in the non-raft regions of the cell membrane; however, during T cell activation, it has been proposed that CD45 comes close proximity to the raft by 
Fluorescence of total input cell Background T-cell migration was determined using the average number of cell migrating into the lower chamber in the absence of chemokine. At all times, the baseline was maintained for 300 seconds followed by addition of CXCL12 (100ng/ml) or DM (1μM) in the cuvette. A second addition of CXCL12 was performed at 700 seconds to assess receptor desensitization.
Ionomycin was added at 1000 second of all samples to assess Fura load and cellular viability and responsiveness. In the DM-treated groups, the cells were pretreated with were treated with CXCL12 (100ng/ml) and DM (1μM) alone or in combination for 5 minutes and after which the cells were lysed with a phosphate free lysis buffer supplied by the manufacturer. CD45 was immunoprecipitated using monoclonal antibody after which the phosphatase activity was assayed. A phosphoprotein was utilized as a substrate with total reaction volume 100μl over a 30 minute incubation period in which 50μg of experimental sample was added. The activity was calculated from an inorganic phosphate standard curve. Finally, the specific phosphatase activity was expressed in nMol phosphate/min/mg of protein. Also, the presence of CD45 in the lysate was confirmed by Immunoprecipitation and immunoblotting of phospho-Lck and total Lck was performed and the data is presented as described in Fig 1A. It should be noted that the ability of DM to inhibit the serine phosphorylation of Lck (shown in Sup Fig 1B) suggests that the lower band noted as IgG in these gels may also be a different gel migrating form of h. 10% donkey serum was utilized for 1 h at 37ºC to block the slides followed by staining with anti-CD45 antibody for 1 h. The cells were then permeabilized with 90% methanol for 30 minutes at -20ºC. Anti-Lck and glucocorticoid receptor antibodies were added together in blocking buffer and the slides were incubated overnight at 4ºC. Secondary antibody corresponding for each primary antibody labeled with alexflour-555, alexflour-647 and alexflour-488 for the Lck, GR and CD45, respectively, were added to the slides and incubated for 1 h at room temperature. The slides were then mounted with Prolong Gold (Invitrogen, Carlsbad, CA) mounting media and image acquisition was done by a confocal microscope (Carl Zeiss, Thornwood, NY) as previously described [50] [51] . Isotype controls for each primary antibody were also utilized in parallel as negative controls. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
